Zentalis Pharmaceuticals ... (ZNTL)
NASDAQ: ZNTL
· Real-Time Price · USD
1.59
0.11 (7.43%)
At close: Aug 15, 2025, 3:59 PM
1.56
-2.19%
After-hours: Aug 15, 2025, 07:25 PM EDT
Zentalis Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 37.6M | 41.93M | 33.9M | 41.32M | 36.98M | 37.62M | 28.04M | 110.75M | 266.56M | 36.28M | 43.07M | 42.55M | 55.14M | 30.57M | 59.71M | 40.81M | 49.17M | 29M |
Short-Term Investments | 265.83M | 290.52M | 337.18M | 349.93M | 389.41M | 451.37M | 454.88M | 405.89M | 286.43M | 356.24M | 394.3M | 379.18M | 400.08M | 258.8M | 280.17M | 325.98M | 201.73M | 269.38M |
Long-Term Investments | n/a | n/a | n/a | 2.63M | 2.68M | 2.68M | 2.68M | n/a | 2.63M | 18.9M | 21.21M | 28.04M | 30.41M | 35.74M | 37.49M | 39.33M | 3.02M | 3.26M |
Other Long-Term Assets | 5.85M | 5.97M | 7.04M | 5.61M | 9.52M | 6.85M | 6.82M | 13.77M | 10.54M | 12.12M | -1.8M | 12.86M | 14.56M | 12.79M | 2.63M | 3.02M | 5.51M | 2.79M |
Receivables | 2.45M | n/a | 5M | n/a | n/a | n/a | n/a | n/a | 1.79M | n/a | 6.53M | n/a | 5.17M | 4.21M | 2.63M | 108K | 1.48M | 1.66M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.22M | n/a | -7.04M | -4.21M | -5.17M | n/a | n/a | 243K | n/a | n/a |
Other Current Assets | 5.71M | 10.43M | 9.98M | n/a | 13.23M | 14.82M | 13.8M | n/a | 932K | 17.71M | 8.03M | n/a | n/a | 243K | n/a | 243K | 243K | n/a |
Total Current Assets | 311.6M | 342.88M | 386.07M | 400.27M | 439.62M | 503.81M | 496.72M | 528.26M | 563.93M | 410.23M | 451.93M | 433.89M | 467.63M | 301.28M | 350.77M | 377.56M | 259.45M | 306.35M |
Property-Plant & Equipment | 34.26M | 35.17M | 37.23M | 38.42M | 38.81M | 40.41M | 41.73M | 42.58M | 43.23M | 44.35M | 50.08M | 50.67M | 51.52M | 52.12M | 52.84M | 5.39M | 3.45M | 3.41M |
Goodwill & Intangibles | n/a | n/a | n/a | 3.74M | 3.74M | 3.74M | 3.74M | 3.74M | 3.74M | 3.74M | 3.74M | 3.74M | 3.74M | 3.74M | 3.74M | 3.74M | 12.54M | 12.54M |
Total Long-Term Assets | 40.11M | 41.14M | 44.27M | 50.39M | 52.06M | 53.67M | 65.31M | 57.45M | 57.52M | 79.12M | 87.38M | 95.3M | 100.23M | 104.39M | 103.74M | 57.52M | 24.51M | 22M |
Total Assets | 351.71M | 384.02M | 430.34M | 450.66M | 491.68M | 557.48M | 562.03M | 585.72M | 621.44M | 489.34M | 539.31M | 529.19M | 567.86M | 405.68M | 454.51M | 435.08M | 283.96M | 328.35M |
Account Payables | 3.72M | 7.77M | 7.44M | 8.2M | 20.44M | 10.5M | 14.93M | 14.26M | 12.3M | 12.82M | 11.25M | 9.82M | 12.04M | 13.16M | 11.59M | 8.05M | 8.27M | 8.34M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 403K | 281K | -2.42M | -2.33M | -2.25M | -2.16M | n/a | n/a | n/a | n/a | 767K | 560K | 606K |
Short-Term Debt | 3.63M | n/a | 3.07M | 2.81M | 2.71M | 2.74M | 2.62M | 2.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | -3.63M | n/a | 26.34M | 33.04M | 37.07M | n/a | -2.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20.68M | n/a | n/a | n/a |
Total Current Liabilities | 39.02M | 49.43M | 52.73M | 54.88M | 66.69M | 54.8M | 69.37M | 58.92M | 51.76M | 56.36M | 56.65M | 54.06M | 48.64M | 43.48M | 43.94M | 39.41M | 33.58M | 32.8M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 44.03M | 44.77M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 500K | 558K | 849K | 996K | 1.09M | 1.29M | 1.78M | 1.63M | -41.65M | -42.98M | 2.62M | 45.17M | n/a | n/a | n/a | n/a | 296K | 438K |
Total Long-Term Liabilities | 38.19M | 39.21M | 40.43M | 41.45M | 42.41M | 43.91M | 55.27M | 44.9M | 46.4M | 47.32M | 48.64M | 46.39M | 46.4M | 46.53M | 46.08M | 1.67M | 2.78M | 2.92M |
Total Liabilities | 77.21M | 88.64M | 93.15M | 96.33M | 109.1M | 98.71M | 124.64M | 103.82M | 98.16M | 103.68M | 105.29M | 100.45M | 95.03M | 90.01M | 90.03M | 41.09M | 36.35M | 35.72M |
Total Debt | 37.69M | 38.65M | 39.58M | 43.27M | 44.03M | 45.35M | 45.77M | 45.69M | 46.36M | 44.77M | 45.17M | 2.21M | 46.8M | 46.25M | 45.91M | 862K | 804K | 1.1M |
Common Stock | 72K | 72K | 71K | 71K | 71K | 70K | 70K | 70K | 70K | 59K | 59K | 57K | 57K | 46K | 45K | 45K | 41K | 41K |
Retained Earnings | -1.13B | -1.1B | -1.05B | -1.01B | -966.76M | -878.49M | -888.56M | -827.64M | -772.11M | -659.58M | -596.37M | -541.39M | -486.99M | -418.64M | -359.56M | -309.5M | -305.31M | -250.74M |
Comprehensive Income | 59K | 358K | 558K | 1.59M | 140K | 773K | 2.19M | -359K | -338K | -556K | -1.35M | -2.27M | -1.78M | -1.11M | -125K | 32K | 94K | 50K |
Shareholders Equity | 274.5M | 295.38M | 337.19M | 354.33M | 382.58M | 458.77M | 437.28M | 481.77M | 523.14M | 385.49M | 433.8M | 428.5M | 472.49M | 315.3M | 364.48M | 393.43M | 223.84M | 268.39M |
Total Investments | 265.83M | 290.52M | 337.18M | 349.93M | 392.09M | 454.05M | 457.56M | 405.89M | 286.43M | 356.24M | 415.51M | 407.21M | 430.48M | 294.54M | 317.67M | 365.31M | 201.73M | 269.38M |